SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-136403
Filing Date
2016-11-23
Accepted
2016-11-23 17:01:08
Documents
1
Period of Report
2016-11-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v453758_4.html 4  
1 OWNERSHIP DOCUMENT v453758_4.xml 4 4177
  Complete submission text file 0001144204-16-136403.txt   5686
Mailing Address 205 EAST 42ND STREET, 16TH FLOOR NEW YORK NY 10017
Business Address 205 EAST 42ND STREET, 16TH FLOOR NEW YORK NY 10017 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROTROPE, INE. 205 EAST 42ND STREET - 20TH FLOOR NEW YORK NY 10017
Business Address
Alkon Daniel L. (Reporting) CIK: 0001686138 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55275 | Film No.: 162017198